siRNA therapy reduces triglycerides in people along with rare ailment

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran lessened triglyceride degrees through 80% as well as decreased the threat of pancreatitis in individuals with consistent chylomicronemia, along with or without a genetic prognosis.